Hainan Huluwa Pharmaceutical Group Bronchitis Inhaler Gets NMPA's Approval for Clinical Trials
Hainan Huluwa Pharmaceutical Group Bronchitis Inhaler Gets NMPA's Approval for Clinical Trials
葫蘆娃藥品集團支氣管炎霧化治療劑獲得國家藥品監督管理局批准進行臨床試驗。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊